The leading edge of precision medicine research

I wanted to share some very exciting news as a follow up to my previous blog about Henry Ford Hospital’s investment in precision medicine. Last month, the National Institutes of Health announced that Henry Ford Health System is leading a five-member research consortium to expand the geographic reach and diversity of the NIH’s Precision Medicine Initiative (PMI) Cohort Program.

Led by co-principal investigators Christine Cole Johnson, Ph.D., MPH, chair of Public Health Sciences, and Brian Ahmedani, Ph.D., director of Research for Behavioral Health Medicine, Henry Ford will oversee the enrollment of 10,000 participants in the first year, collect their health information and biospecimens, and provide input on developing plans for the PMI Cohort Program. The Cohort Program has a goal to collectively enroll 1 million participants nationally over several years.

So what does this research study mean for patients? It could potentially lead to more effective preventative measures and treatments for diseases based on a variety of factors, including lifestyle, environment and genetics.

I’m confident we’ll be able to learn more about, and perhaps even solve medical mysteries that have afflicted patients since the beginning of time.

Congratulations to everyone involved in this pioneering study.

Share Doc in the D:

2 thoughts on “The leading edge of precision medicine research

  1. The current model of healthcare delivery is reactive that treats patients’ illnesses after the fact. It needs to evolve into proactive system more focused on patients, ongoing management of chronic conditions and prevention rather than increasing consumption of health services and precision medicine research will bring new insight. Congratulations!

  2. Thank you, Suresh. We’re equally excited about the opportunities resulting from this research.

Comments are closed.